Almost 25% of COVID-19 patients develop long-lasting symptoms, according to a new report.
Almost 25% of COVID-19 Patients Develop Long-Lasting Symptoms, According to a New Report – TIME Original report: A Detailed Study of Patients with Long-Haul COVID – FAIR Health Commentary on Twitter (thread – click for more) ?1 in 4–almost a quarter of people infected develop at least one lingering health problem after 30 days […]
The post Almost 25% of COVID-19 patients develop long-lasting symptoms, according to a new report. appeared first on Links Medicus.
Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series – Annals of Internal Medicine Commentaries: For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection – Hopkins Medicine AND Extra COVID Vaccine May Help Protect Transplant Patients – Associated Press Commentary […]
The post Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients. appeared first on Links Medicus.
Delta variant producing more severe illness, doctors in China say.
In China’s latest outbreak, doctors say the infected get sicker, faster. – The New York Times (a few articles per month are free)
The post Delta variant producing more severe illness, doctors in China say. appeared first on Links Medicus.
A new coronavirus variant (Delta) is on the rise. Here’s why experts are concerned.
A new coronavirus variant is on the rise. Here’s why experts are concerned – CNN
The post A new coronavirus variant (Delta) is on the rise. Here’s why experts are concerned. appeared first on Links Medicus.
Delta variant causes more than 90% of new Covid cases in UK.
Delta variant causes more than 90% of new Covid cases in UK – The Guardian Commentary on Twitter (thread – click for more) ⚠️90-96% of all #COVID19 in ?? caused by #DeltaVariant.? ?32% of all Delta cases visiting the hospital emergency room are at least 1 dose vaccinated ?33% who are then hospitalized vaccinated […]
The post Delta variant causes more than 90% of new Covid cases in UK. appeared first on Links Medicus.
WHO official: Delta variant ‘poised to take hold’ in Europe.
WHO official: Delta variant ‘poised to take hold’ in Europe – The Hill
The post WHO official: Delta variant ‘poised to take hold’ in Europe. appeared first on Links Medicus.
[Preprint] 2 doses of Covid vaccines (Pfizer-BioNTech or Oxford-AstraZeneca) highly effective against hospitalization from Delta variant.
News Release: Vaccines highly effective against hospitalisation from Delta variant – Public Health England Preprint: Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant Commentary on Twitter NEWS — Our new analysis shows for the first time that two doses of the #COVID19 #vaccines are highly effective against hospitalisation from the […]
The post [Preprint] 2 doses of Covid vaccines (Pfizer-BioNTech or Oxford-AstraZeneca) highly effective against hospitalization from Delta variant. appeared first on Links Medicus.
SARS-CoV-2 Delta variant in Scotland: demographics, risk of hospital admission, and vaccine effectiveness – “Risk of COVID-19 hospital admission was approximately doubled in those with the Delta VOC when compared to the Alpha VOC”.
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness – The Lancet Commentaries: Delta may raise hospitalisation but vaccine still protects – UK Research and Innovation AND Expert reaction to Lancet research letter analysing data from Scotland on the Delta variant, looking at demographics, risk of hospital admission and vaccine effectiveness […]
The post SARS-CoV-2 Delta variant in Scotland: demographics, risk of hospital admission, and vaccine effectiveness – “Risk of COVID-19 hospital admission was approximately doubled in those with the Delta VOC when compared to the Alpha VOC”. appeared first on Links Medicus.
(Press release – not published yet) Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease.
Press release: Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial Commentaries: U.S. clinical trial results show Novavax vaccine is safe and prevents COVID-19 – NIH News Releases AND Novavax Covid-19 vaccine highly effective in late-stage trial, long-awaited results show – STAT AND Powerful […]
The post (Press release – not published yet) Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease. appeared first on Links Medicus.
Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape.
Pulmonary exacerbations in Adults With Cystic Fibrosis – CHEST Journal: A Grown-up Issue in a Changing Cystic Fibrosis Landscape – CHEST
The post Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape. appeared first on Links Medicus.